In Brief: Reteplase
Executive Summary
Reteplase: Is Boehringer Mannheim's thrombolytic for use in management of acute MI. The product was recommended for approval by an FDA advisory committee May 3. The Aug. 12 issue of "The Pink Sheet" (p. 13) misattributes reteplase's ownership...